Novartis AG (SWX:NOVNEE)

Market Cap	201.17B
Revenue (ttm)	43.89B
Net Income (ttm)	10.86B
Shares Out	n/a
EPS (ttm)	5.45
PE Ratio	18.53
Forward PE	15.10
Dividend	n/a
Ex-Dividend Date	n/a

Volume	180,000
Average Volume	186,162
Open	101.56
Previous Close	101.34
Day's Range	101.36 - 101.88
52-Week Range	81.55 - 103.26
Beta	0.49
RSI	71.74
Earnings Date	Oct 28, 2025

About Novartis AG

Novartis AG engages in the research, development, manufacture, distribution, marketing, and sale of pharmaceutical medicines in Switzerland and internationally. The company offers Entresto, an angiotensin receptorneprilysin inhibitor for the treatment of symptomatic chronic heart failure with reduced ejection fraction (HFrEF); Cosentyx to treat plaque psoriasis, pso riatic arthritis, ankylosing spondylitis, and nonradiographic axial spondy loarthritis; Kisqali, a selective oral cyclin dependent inhibitor of kinases 4 and 6 (CDK4/6); Promacta/Re...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 1996
• Employees: 75,883
• Stock Exchange: SIX Swiss Exchange
• Ticker Symbol: NOVNEE

Financial Performance

In 2024, Novartis AG's revenue was $51.72 billion, an increase of 10.85% compared to the previous year's $46.66 billion. Earnings were $11.94 billion, a decrease of -19.59%.

Financial numbers in USD